The Can Ruti Campus and the healthcare and research teams from the various institutions that form it continue, for another year, to stand out as a global scientific hub in terms of production and scientific advancement.

Once again, the names of around thirty renowned professionals - from the Hospital and the Germans Trias i Pujol Research Institute (IGTP), the Fight Infections Foundation, IrsiCaixa, the Josep Carreras Leukaemia Research Institute (IJC), and the Institut Català d'Oncologia (ICO) - appear on a global list of scientists who have achieved the highest impact through their publications and citations.

This list is the latest update of Elsevier's Scopus database, a leading global publisher in Medicine and Health Sciences. It includes around 200,000 authors, covering 22 research fields and 174 sub-fields, based on bibliometric data.

Selection criteria include factors such as the number of publications, the quality of the journals they have published in, the number of citations received throughout their career, and other indicators that reflect the influence and prestige of their scientific contributions. The final list includes those in the top 2% or higher of their area of expertise worldwide.

The list categorises professionals into two groups: those recognised for their impact over the past year and those recognised for their entire scientific career.

For the impact of their work during 2023, the following names are included:

• Esteban Ballestar, Group Leader, Epigenetics and Immune Diseases at IJC

• Jordi Barretina, current Director of IGTP

• Antoni Bayés, Clinical Director of the Heart Institute at Germans Trias and principal investigator of the Heart Failure and Cardiac Regeneration Research Group (ICREC) at IGTP

• Jaume Canet, former Head of the Anaesthesia and Resuscitation Service at the Hospital

• Pere Joan Cardona, Head of the Microbiology Service at the Hospital and principal investigator of the Clinical and Experimental Microbiology Research Group at IGTP

• José Manuel Carrascosa, Head of the Dermatology Service at the Hospital

• Enric Carreras, Group Leader, Barcelona Endothelium Team (BET) at IJC and member of the Josep Carreras International Foundation against Leukaemia

• Bonaventura Clotet, President of the Fight Infections Foundation and Director of IrsiCaixa

• Antoni Dávalos, former Clinical Director of Neurosciences at the Hospital and member of the Neurovascular Research Group at IGTP

• Victoria Delgado, Head of the Cardiovascular Imaging Section at Germans Trias and Scientific Director of the Comparative Medicine and Imaging Centre of Catalonia (CMCiB)

• Manel Esteller, Group Leader in Cancer Epigenetics at IJC

• Magí Farré, Head of Clinical Pharmacology and responsible for the Clinical Research Unit (UPIC) at IGTP

• Josep Maria Llibre, attending physician in the HIV unit at the Hospital and researcher at the Fight Infections Foundation

• Josep Lupón, Head of the Cardiology Service at the Hospital

• Fernando Marqués-Garcia, specialist in Clinical Analysis and Clinical Biochemistry at the Clinical Laboratory of the Hospital

• Javier Martínez-Picado, principal investigator at IrsiCaixa and ICREA professor

• Ricard Mesía, Head of the Medical Oncology Service at ICO

• Oriol Mitjà, Head of the Infectious Diseases Section at the Hospital and Head of Community Infection Control Strategies at the Fight Infections Foundation

• Roger Paredes, Head of the Infectious Diseases Service at the Hospital, principal investigator at IrsiCaixa and Scientific Director of the Fight Infections Foundation

• Josep-Maria Ribera, Group Leader, Acute Lymphoblastic Leukaemia at IJC

• Montse Sanchez-Céspedes, Group Leader, Cancer Genetics at IJC

• Cristian Tebé, Head of the Biostatistics Platform at IGTP

For their entire career, the list includes many of the above names, as well as:

• Eugeni Domènech, Head of the Digestive System Service at the Hospital

• Miquel Àngel Gassull, former IGTP Director and expert in inflammatory bowel disease

• Manuel Perucho, former director of the predictive and personalised medicine programme at IGTP

• Ciril Rozman, scientific founder of IJC

• Fumiichiro Yamamoto, Group Leader, Immunohaematology and Glycobiology at IJC

Reference Article: Ioannidis, John P.A. (2024), August 2024 data-update for "Updated science-wide author databases of standardised citation indicators". Elsevier Data Repository. 2024 Sep 16; V7. DOI: 10.17632/btchxktzyw.7